Pain Management for Special Feline Cases

Mathews, K. A. (2008). "Pain management for the pregnant, lactating, and neonatal to pediatric cat and dog." Vet Clin North Am Small Anim Pract 38(6): 1291-308, vi-vii.

The majority of the information available to veterinarians on pain management for small animals is for the mature patient. Pregnant and lactating queens and neonates have received little attention or investigation. Unfortunately, this means that pain management is often avoided for these patients, due to concerns over adverse effects. The purpose of this review article is to focus on commonly available analgesics for these special patients. During pregnancy, opioids are the preferred analgesic for both women and animals. For example, opioids may be used to control pain associated with caesarean section with little or no effect on neonates. For lactating animals, opioids and non-steroidal anti-inflammatory drugs may be used. Opioids are also often used for pediatric patients, while non-steroidal anti-inflammatories are avoided in animals under 6 weeks of age. The risks and benefits of each class of drug, as well as a table of drugs and dosages are included. Dissemination of such information will help provide pain relief to some of the most vulnerable patients in veterinary medicine. [SL]
>> PubMed Abstract

Related articles:
Dyson, D. H. (2008). "Perioperative Pain Management in Veterinary Patients." The Veterinary clinics of North America. Small animal practice 38(6): 1309-1327.
>> PubMed Abstract

Robertson, S. and P. Taylor (2004). "Pain management in cats - past, present and future. Part 2. Treatment of pain - clinical pharmacology." J Fel Med Surg 6(5): 321-333.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library

Mathews, K. A. (2008). "Pain management for the pregnant, lactating, and neonatal to pediatric cat and dog." Vet Clin North Am Small Anim Pract 38(6): 1291-308, vi-vii.

The majority of the information available to veterinarians on pain management for small animals is for the mature patient. Pregnant and lactating queens and neonates have received little attention or investigation. Unfortunately, this means that pain management is often avoided for these patients, due to concerns over adverse effects. The purpose of this review article is to focus on commonly available analgesics for these special patients. During pregnancy, opioids are the preferred analgesic for both women and animals. For example, opioids may be used to control pain associated with caesarean section with little or no effect on neonates. For lactating animals, opioids and non-steroidal anti-inflammatory drugs may be used. Opioids are also often used for pediatric patients, while non-steroidal anti-inflammatories are avoided in animals under 6 weeks of age. The risks and benefits of each class of drug, as well as a table of drugs and dosages are included. Dissemination of such information will help provide pain relief to some of the most vulnerable patients in veterinary medicine. [SL]
>> PubMed Abstract

Related articles:
Dyson, D. H. (2008). "Perioperative Pain Management in Veterinary Patients." The Veterinary clinics of North America. Small animal practice 38(6): 1309-1327.
>> PubMed Abstract

Robertson, S. and P. Taylor (2004). "Pain management in cats - past, present and future. Part 2. Treatment of pain - clinical pharmacology." J Fel Med Surg 6(5): 321-333.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library

Read More

Feline Eosinophilic Keratitis

Spiess, A. K., J. S. Sapienza, et al. (2009). "Treatment of proliferative feline eosinophilic keratitis with topical 1.5% cyclosporine: 35 cases." Vet Ophthalmol 12(2): 132-7.

Eosinophilic keratitis is a progressive corneal disease seen in cats of any age. While the etiology is unknown, an immune-mediated response to feline herpesvirus is a suspected cause. The disease is unilateral in up to 75% of cases. The lesions are typically raised, irregular, white to pink masses. Scrapings of the lesions contain eosinophils, mast cells, and mixed inflammatory cells. Treatment is with topical corticosteroids, although some cases become refractory. Relapse is common if treatment is discontinued. The purpose of this study was to evaluate the efficacy of topical cyclosporine for feline eosinophilic keratitis. The disease was diagnosed by clinical appearance and corneal cytology in 35 cats. The mean age of affected cats was 6 years. Topical cyclosporine was administered either two or three times daily. The minimum follow up period was 5 months. Improvement was seen in 89% of cats. Recurrence was seen in 23% of cases. The researchers conclude that topical cyclosporine is an effective treatment for the majority of cats with eosinophilic keratitis, and that chronic, often life-long therapy is recommended. [SL]
>> PubMed Abstract

Related articles:
Andrew, S. E. (2008). "Immune-mediated canine and feline keratitis." The Veterinary clinics of North America. Small animal practice 38(2): 269-290.
>> PubMed Abstract

Moore, P. A. (2005). "Feline corneal disease." Clin Tech Small Anim Pract 20(2): 83-93.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library

Spiess, A. K., J. S. Sapienza, et al. (2009). "Treatment of proliferative feline eosinophilic keratitis with topical 1.5% cyclosporine: 35 cases." Vet Ophthalmol 12(2): 132-7.

Eosinophilic keratitis is a progressive corneal disease seen in cats of any age. While the etiology is unknown, an immune-mediated response to feline herpesvirus is a suspected cause. The disease is unilateral in up to 75% of cases. The lesions are typically raised, irregular, white to pink masses. Scrapings of the lesions contain eosinophils, mast cells, and mixed inflammatory cells. Treatment is with topical corticosteroids, although some cases become refractory. Relapse is common if treatment is discontinued. The purpose of this study was to evaluate the efficacy of topical cyclosporine for feline eosinophilic keratitis. The disease was diagnosed by clinical appearance and corneal cytology in 35 cats. The mean age of affected cats was 6 years. Topical cyclosporine was administered either two or three times daily. The minimum follow up period was 5 months. Improvement was seen in 89% of cats. Recurrence was seen in 23% of cases. The researchers conclude that topical cyclosporine is an effective treatment for the majority of cats with eosinophilic keratitis, and that chronic, often life-long therapy is recommended. [SL]
>> PubMed Abstract

Related articles:
Andrew, S. E. (2008). "Immune-mediated canine and feline keratitis." The Veterinary clinics of North America. Small animal practice 38(2): 269-290.
>> PubMed Abstract

Moore, P. A. (2005). "Feline corneal disease." Clin Tech Small Anim Pract 20(2): 83-93.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library

Read More